(Q43047944)

12 November 2017

Economic model of a birth cohort screening program for hepatitis C virus (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

9

Milton C Weinstein

1 reference

12 November 2017

1

Lisa J McGarry

1 reference

12 November 2017

Vivek S Pawar

2

1 reference

12 November 2017

Hemangi R Panchmatia

3

1 reference

12 November 2017

Jaime L Rubin

4

1 reference

12 November 2017

Gary L Davis

5

1 reference

12 November 2017

Zobair M Younossi

6

1 reference

12 November 2017

James C Capretta

7

1 reference

12 November 2017

Michael J O'Grady

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

18 March 2012

1 reference

12 November 2017

1 reference

12 November 2017

55

1 reference

12 November 2017

5

1 reference

12 November 2017

1344-1355

1 reference

The prevalence of hepatitis C virus infection in the United States, 1988 through 1994

12 November 2017

1 reference

Aging of hepatitis C virus (HCV)-infected persons in the United States: a multiple cohort model of HCV prevalence and disease progression

21 January 2018

1 reference

The changing epidemiology and natural history of hepatitis C virus infection

21 January 2018

1 reference

21 January 2018

1 reference

Direct economic burden of chronic hepatitis C virus in a United States managed care population

21 January 2018

1 reference

Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons

21 January 2018

1 reference

Telaprevir and peginterferon with or without ribavirin for chronic HCV infection

21 January 2018

1 reference

Efficacy of boceprevir, an NS3 protease inhibitor, in combination with peginterferon alfa-2b and ribavirin in treatment-naive patients with genotype 1 hepatitis C infection (SPRINT-1): an open-label, randomised, multicentre phase 2 trial

21 January 2018

1 reference

Public health impact of antiviral therapy for hepatitis C in the United States

21 January 2018

1 reference

Management of hepatitis C patients by primary care physicians in the USA: results of a national survey

21 January 2018

1 reference

Long-term effectiveness and cost-effectiveness of screening for hepatitis C virus infection.

21 January 2018

1 reference

Cost effectiveness of screening for hepatitis C virus in asymptomatic, average-risk adults.

21 January 2018

1 reference

The prevalence of hepatitis C virus infection in the United States, 1999 through 2002

21 January 2018

1 reference

An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group

21 January 2018

1 reference

Report of nationally representative values for the noninstitutionalized US adult population for 7 health-related quality-of-life scores.

21 January 2018

1 reference

Assessment of hepatitis C virus RNA and genotype from 6807 patients with chronic hepatitis C in the United States

21 January 2018

1 reference

Hepatitis C virus genotypes and viral concentrations in participants of a general population survey in the United States

21 January 2018

1 reference

Insurance status and treatment candidacy of hepatitis C patients: analysis of population-based data from the United States

21 January 2018

1 reference

Fibrosis progression in initially mild chronic hepatitis C.

21 January 2018

1 reference

Telaprevir for previously untreated chronic hepatitis C virus infection

21 January 2018

1 reference

Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis

21 January 2018

1 reference

Cost effectiveness of interferon alpha2b combined with ribavirin for the treatment of chronic hepatitis C.

21 January 2018

1 reference

Assessment of utilities and health-related quality of life in patients with chronic liver disease.

21 January 2018

1 reference

The impact of diagnosis of hepatitis C virus on quality of life.

21 January 2018

1 reference

Cost-effectiveness of HIV screening in patients older than 55 years of age.

21 January 2018

1 reference

Expanded HIV screening in the United States: effect on clinical outcomes, HIV transmission, and costs.

21 January 2018

1 reference

Treatment of hepatitis C in 2011: what can we expect?

21 January 2018

1 reference

Outcomes of treatment for hepatitis C virus infection by primary care providers

21 January 2018

1 reference

Cost-effectiveness of 6 and 12 months of interferon-alpha therapy for chronic hepatitis C

21 January 2018

1 reference

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/HEP.25510

1 reference

12 November 2017

1 reference